|
1
|
Neagu M, Caruntu C, Constantin C, Boda D,
Zurac S, Spandidos DA and Tsatsakis AM: Chemically induced skin
carcinogenesis: Updates in experimental models (Review). Oncol Rep.
35:2516–2528. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karimkhani C, Green AC, Nijsten T,
Weinstock MA, Dellavalle RP, Naghavi M and Fitzmaurice C: The
global burden of melanoma: Results from the Global Burden of
Disease Study 2015. Br J Dermatol. 177:134–140. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Forsea AM, Del Marmol V, de Vries E,
Bailey EE and Geller AC: Melanoma incidence and mortality in
Europe: New estimates, persistent disparities. Br J Dermatol.
167:1124–1130. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barbaric J, Sekerija M, Agius D, Coza D,
Dimitrova N, Demetriou A, Safaei Diba C, Eser S, Gavric Z,
Primic-Zakelj M, et al: Disparities in melanoma incidence and
mortality in South-Eastern Europe: Increasing incidence and
divergent mortality patterns. Is progress around the corner? Eur J
Cancer. 55:47–55. 2016.PubMed/NCBI
|
|
5
|
European Cancer Information System:
Measuring cancer burden and its time trends across. https://ecis.jrc.ec.europa.eu
|
|
6
|
Rockberg J, Amelio JM, Taylor A, Jörgensen
L, Ragnhammar P and Hansson J: Epidemiology of cutaneous melanoma
in Sweden-Stage-specific survival and rate of recurrence. Int J
Cancer. 139:2722–2729. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Forsea AM, Del Marmol V, Stratigos A and
Geller AC: Melanoma prognosis in Europe: Far from equal. Br J
Dermatol. 171:179–182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Crocetti E, Mallone S, Robsahm TE, Gavin
A, Agius D, Ardanaz E, Lopez MC, Innos K, Minicozzi P, Borgognoni
L, et al EUROCARE-5 Working Group, : Survival of patients with skin
melanoma in Europe increases further: Results of the EUROCARE-5
study. Eur J Cancer. 51:2179–2190. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zurac S, Neagu M, Constantin C, Cioplea M,
Nedelcu R, Bastian A, Popp C, Nichita L, Andrei R, Tebeica T, et
al: Variations in the expression of TIMP1, TIMP2 and TIMP3 in
cutaneous melanoma with regression and their possible function as
prognostic predictors. Oncol Lett. 11:3354–3360. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Caruntu C, Boda D, Constantin C, Caruntu A
and Neagu M: Catecholamines increase in vitro proliferation of
murine B16F10 melanoma cells. Acta Endo. 10:545–558. 2014.
View Article : Google Scholar
|
|
11
|
Boda D: Cellomics as integrative omics for
cancer. Curr Proteomics. 10:237–245. 2013. View Article : Google Scholar
|
|
12
|
Rotaru M, Nati AE, Avrămoiu I, Grosu F and
Mălăescu GD: Digital dermoscopic follow-up of 1544 melanocytic
nevi. Rom J Morphol Embryol. 56:1467–1472. 2015.PubMed/NCBI
|
|
13
|
Watson M, Geller AC, Tucker MA, Guy GP Jr
and Weinstock MA: Melanoma burden and recent trends among
non-Hispanic whites aged 15–49 years, United States. Prev Med.
91:294–298. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tripp MK, Watson M, Balk SJ, Swetter SM
and Gershenwald JE: State of the science on prevention and
screening to reduce melanoma incidence and mortality: The time is
now. CA Cancer J Clin. 66:460–480. 2016. View Article : Google Scholar
|
|
15
|
McMasters KM, Sondak VK, Lotze MT and Ross
MI: Recent advances in melanoma staging and therapy. Ann Surg
Oncol. 6:467–475. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Balch CM, Gershenwald JE, Soong SJ,
Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG,
Ding S, et al: Final version of 2009 AJCC melanoma staging and
classification. J Clin Oncol. 27:6199–6206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gershenwald JE, Scolyer RA, Hess KR,
Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM,
McArthur GA, et al: Melanoma staging: Evidence-based changes in the
American Joint Committee on Cancer eighth edition cancer staging
manual. CA Cancer J Clin. 67:472–492. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Enninga EAL, Moser JC, Weaver AL, Markovic
SN, Brewer JD, Leontovich AA, Hieken TJ, Shuster L, Kottschade LA,
Olariu A, et al: Survival of cutaneous melanoma based on sex, age,
and stage in the United States, 1992–2011. Cancer Med. 6:2203–2212.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Populaţia României pe localităţi (după
domiciliu), . Institutul Naţional de Statistică România. http://www.insse.ro/cms/sites/default/files/field/publicatii/populatia_romaniei_dupa
domiciliu_la_1_iul_2016_0.pdfJuly 1–2016
|
|
20
|
Youlden DR, Baade PD, Soyer HP, Youl PH,
Kimlin MG, Aitken JF, Green AC and Khosrotehrani K: Ten-year
survival after multiple invasive melanomas is worse than after a
single melanoma: A Population-Based Study. J Invest Dermatol.
136:2270–2276. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sacchetto L, Zanetti R, Comber H,
Bouchardy C, Brewster DH, Broganelli P, Chirlaque MD, Coza D,
Galceran J, Gavin A, et al: Trends in incidence of thick, thin and
in situ melanoma in Europe. Eur J Cancer. 92:108–118. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsoutsos D, Papadopoulos S, Kehagias G,
Mara A, Kyriopoulou E, Karonidis A, Spiliopoulos K, Mpalitsaris E,
Karapiperis G, Panayotou P, et al: Epidemiological trends in the
diagnosis of melanoma in a Southern European population: Analysis
of a large database from a tertiary referral center. Melanoma Res.
28:348–358. 2018.PubMed/NCBI
|
|
23
|
Astrua C, Fava P, Brizio M and Savoia P: A
study of melanoma in Eastern European migrants in Italy. Eur J
Dermatol. 27:139–143. 2017.PubMed/NCBI
|
|
24
|
van der Leest RJ, Zoutendijk J, Nijsten T,
Mooi WJ, van der Rhee JI, de Vries E and Hollestein LM: Increasing
time trends of thin melanomas in The Netherlands: What are the
explanations of recent accelerations? Eur J Cancer. 51:2833–2841.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Helvind NM, Hölmich LR, Smith S, Glud M,
Andersen KK, Dalton SO and Drzewiecki KT: Incidence of in situ and
invasive melanoma in Denmark from 1985 through 2012: A National
Database Study of 24,059 melanoma cases. JAMA Dermatol.
151:1087–1095. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Andersson TM, Eriksson H, Hansson J,
Månsson-Brahme E, Dickman PW, Eloranta S, Lambe M and Lambert PC:
Estimating the cure proportion of malignant melanoma, an
alternative approach to assess long term survival: A
population-based study. Cancer Epidemiol. 38:93–99. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eriksson H, Lyth J, Månsson-Brahme E,
Frohm-Nilsson M, Ingvar C, Lindholm C, Naredi P, Stierner U,
Carstensen J and Hansson J: Later stage at diagnosis and worse
survival in cutaneous malignant melanoma among men living alone: A
nationwide population-based study from Sweden. J Clin Oncol.
32:1356–1364. 2014. View Article : Google Scholar : PubMed/NCBI
|
